-
41
Phase I study of efineptakin alfa (NT-I7) for the treatment of Kaposi sarcoma
Published 2025-02-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
42
Clinicopathological and predictive value of MAIT cells in non-small cell lung cancer for immunotherapy
Published 2023-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
43
Sex and outcomes of patients with microsatellite instability-high and BRAF V600E mutated metastatic colorectal cancer receiving immune checkpoint inhibitors
Published 2025-02-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
44
Anti-VEGF therapy improves EGFR-vIII-CAR-T cell delivery and efficacy in syngeneic glioblastoma models in mice
Published 2023-03-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
45
Tumor-infiltrating lymphocytes mediate complete and durable remission in a patient with NY-ESO-1 expressing prostate cancer
Published 2023-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
46
First-in-human, multicenter, open-label, phase I study of ATOR-1017 (evunzekibart), a 4-1BB antibody, in patients with advanced solid malignancies
Published 2025-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
47
Next-generation ctDNA-driven clinical trials in precision immuno-oncology
Published 2023-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
48
Extracellular HMGB1 blockade inhibits tumor growth through profoundly remodeling immune microenvironment and enhances checkpoint inhibitor-based immunotherapy
Published 2021-03-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
49
Combined PARP14 inhibition and PD-1 blockade promotes cytotoxic T cell quiescence and modulates macrophage polarization in relapsed melanoma
Published 2025-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
50
T-cell receptor beta variable gene polymorphism predicts immune-related adverse events during checkpoint blockade immunotherapy
Published 2023-08-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
51
Intrathecal trastuzumab: immunotherapy improves the prognosis of leptomeningeal metastases in HER-2+ breast cancer patient
Published 2015-09-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
52
Endothelial Activation and Stress Index (EASIX) to predict mortality after allogeneic stem cell transplantation: a prospective study
Published 2024-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
53
What’s in a name? Memory NK cells for cancer immunotherapy
Published 2025-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
54
Perioperative pembrolizumab in early-stage non-small cell lung cancer (NSCLC): safety, efficacy, and exploratory biomarker analysis
Published 2025-02-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
55
SARS-CoV-2 infections in pediatric and young adult recipients of chimeric antigen receptor T-cell therapy: an international registry report
Published 2023-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
56
Machine learning analysis of pathological images to predict 1-year progression-free survival of immunotherapy in patients with small-cell lung cancer
Published 2024-02-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
57
Immune and genomic biomarkers of immunotherapy response in cancer of unknown primary
Published 2023-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
58
Phase II, single-arm trial of preoperative short-course radiotherapy followed by chemotherapy and camrelizumab in locally advanced rectal cancer
Published 2021-11-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
59
Comparative impact of tertiary lymphoid structures and tumor-infiltrating lymphocytes in cholangiocarcinoma
Published 2025-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
60
UBE2T/CDC42/CD276 signaling axis mediates brain metastasis of triple-negative breast cancer via lysosomal autophagy
Published 2025-02-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article